Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitis.
about
Impact of thiopurines and anti-tumour necrosis factor therapy on hospitalisation and long-term surgical outcomes in ulcerative colitisOptimal management of steroid-dependent ulcerative colitisTumor necrosis factor-α signaling in macrophages.Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update.The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitisNovel topical therapies for distal colitis.Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease.What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study.Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis.Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit
P2860
Q26771136-5328C7ED-A4FC-4344-ADD2-1E73A6159A23Q26773203-39889274-9EB9-4D73-A9D5-9FF82E8D130BQ34734335-06D9C085-D708-4E6C-93D5-D7E30EA06AC5Q35026302-572F6F96-8094-4EBA-9B58-F2F5BD04BCECQ37141131-A16BEDFE-6E8A-49C5-8023-9F59A507EC5FQ37876204-384E7108-D415-4CCC-8726-675CEA8181E5Q38011773-10942105-2021-40EE-ADD0-D03FA60F759CQ38191583-67775B8C-3FF1-425E-863C-FE4943B0E0D7Q42648367-55C52D53-C88F-4887-9744-185134E552EAQ43496310-5F091A57-FBCD-4D51-B915-3708932AE147Q44979663-7F3D498C-15BA-4D14-9FB6-DF7622DBB464Q46130626-37E61D36-E838-4254-AE62-D38FC5364386Q50891880-A75DBED4-1F3F-4C1C-B48A-1C8E208D160BQ57789396-A636BA5D-DFC2-4A72-9B0A-49324247A047
P2860
Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of infliximab in the preve ...... refractory ulcerative colitis.
@en
Use of infliximab in the preve ...... refractory ulcerative colitis.
@nl
type
label
Use of infliximab in the preve ...... refractory ulcerative colitis.
@en
Use of infliximab in the preve ...... refractory ulcerative colitis.
@nl
prefLabel
Use of infliximab in the preve ...... refractory ulcerative colitis.
@en
Use of infliximab in the preve ...... refractory ulcerative colitis.
@nl
P2860
P356
P1476
Use of infliximab in the preve ...... refractory ulcerative colitis.
@en
P2093
Ian Craig Lawrance
Robert P Willert
P2860
P304
P356
10.3748/WJG.14.2544
P407
P577
2008-04-01T00:00:00Z